Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Homologous Recombination02:31

Homologous Recombination

50.3K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.3K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

5.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
5.9K
CRISPR01:59

CRISPR

49.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Identification of RNA binding proteins targeting TP53, RB1 and PTEN in colorectal cancer as potential biomarkers for diagnosis, drug resistance, sensitivity and prognosis.

Discover oncology·2026
Same author

Preliminary screening reveals HPV-derived cDNA in the HNCF-PI 52 cell line originally derived from normal cervical tissue.

Journal of virological methods·2026
Same author

Lapatinib-Loaded Glucose-Functionalized Silver Nanoparticles Enhance Efficacy in HER2-Positive Breast Cancer Cells and Modulate Survival-Associated Genes.

Pharmaceutical research·2026
Same author

LENG8-AS1: A Prognostic Biomarker in Colorectal Cancer-Differential Expression and Clinical Implications.

Indian journal of clinical biochemistry : IJCB·2026
Same author

TMEM105 upregulation promotes colorectal cancer malignancy: a novel prognostic biomarker potentially linked to the MYC-Ribosome biogenesis axis.

Cancer cell international·2026
Same author

Overexpression of cancer testis antigens in gastric cancer and their correlations with the patients' clinicopathological characteristics.

BMC medical genomics·2025

相关实验视频

Updated: Jun 11, 2025

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
10:16

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases

Published on: August 16, 2024

1.1K

KRAS突变检测方法:从RFLP到基于CRISPR/Cas的方法

Firouzeh Morshedzadeh1, Mohammad Reza Abbaszadegan2,3, Maryam Peymani4

  • 1Department of Genetics, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.

Functional & integrative genomics
|October 4, 2024
PubMed
概括

识别KRAS突变对于个性化癌症治疗至关重要. 本综述涵盖了用于检测这些突变的数字滴滴PCR,NGS和PCR等方法,有助于向治疗选择.

关键词:
克拉斯 (Kras) 是一个国家.分子诊断方法 分子诊断方法个性化癌症药物 个性化癌症药物这是RAS家族的RAS家族.

更多相关视频

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
10:07

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

7.8K
Using a Fluorescent PCR-capillary Gel Electrophoresis Technique to Genotype CRISPR/Cas9-mediated Knockout Mutants in a High-throughput Format
08:25

Using a Fluorescent PCR-capillary Gel Electrophoresis Technique to Genotype CRISPR/Cas9-mediated Knockout Mutants in a High-throughput Format

Published on: April 8, 2017

13.8K

相关实验视频

Last Updated: Jun 11, 2025

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
10:16

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases

Published on: August 16, 2024

1.1K
A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
10:07

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

7.8K
Using a Fluorescent PCR-capillary Gel Electrophoresis Technique to Genotype CRISPR/Cas9-mediated Knockout Mutants in a High-throughput Format
08:25

Using a Fluorescent PCR-capillary Gel Electrophoresis Technique to Genotype CRISPR/Cas9-mediated Knockout Mutants in a High-throughput Format

Published on: April 8, 2017

13.8K

科学领域:

  • 在瘤学瘤学.
  • 分子生物学分子生物学
  • 遗传学 遗传学 是一个

背景情况:

  • KRAS突变是个性化癌症医学中的关键生物标志物.
  • 准确识别KRAS突变可以指导治疗决策并改善患者的治疗结果.
  • 了解KRAS突变状态对于选择适当的向疗法至关重要.

研究的目的:

  • 提供当前KRAS突变检测方法的全面审查.
  • 突出快速可靠的KRAS突变发现的重要性.
  • 引导临床医生识别KRAS突变,以有效治疗癌症.

主要方法:

  • 审查已建立和新兴的分子测试技术.
  • 讨论包括数字滴滴PCR,下一代测序 (NGS) 和聚合酶连锁反应 (PCR) 的方法.
  • 分析诸如瘤异质性和抵抗机制等挑战.

主要成果:

  • 各种分子方法提供有效的KRAS突变检测.
  • 快速可靠的检测有助于个性化治疗策略.
  • 了解局限性对于准确的解释至关重要.

结论:

  • 对于指导向癌症治疗,KRAS突变检测是不可或缺的.
  • 检测方法的不断进步正在改善患者的护理.
  • 本综述作为KRAS突变识别的临床指南.